Affinity Drug Design Limited Micro-entity accounts

Affinity Drug Design Limited Micro-entity accounts

AFFINITY DRUG DESIGN LIMITED - Company Information

Print Friendly Version

false false false false false false false false false true false false false false false false false No description of principal activity 2016-04-01 Sage Accounts Production Advanced 2017 Update 1 - FRS xbrli:pure xbrli:shares iso4217:GBP 08466627 2016-04-01 2017-03-31 08466627 2017-03-31 08466627 2016-03-31 08466627 bus:Director1 2016-04-01 2017-03-31 08466627 bus:Director2 2016-04-01 2017-03-31 08466627 core:WithinOneYear 2017-03-31 08466627 core:WithinOneYear 2016-03-31 08466627 core:RestatedAmount 2016-03-31 08466627 bus:Micro-entities 2016-04-01 2017-03-31 08466627 bus:AuditExemptWithAccountantsReport 2016-04-01 2017-03-31 08466627 bus:FullAccounts 2016-04-01 2017-03-31 08466627 bus:SmallCompaniesRegimeForAccounts 2016-04-01 2017-03-31 08466627 bus:PrivateLimitedCompanyLtd 2016-04-01 2017-03-31
COMPANY REGISTRATION NUMBER: 08466627
Affinity Drug Design Limited
Filleted Unaudited Financial Statements
31 March 2017
Affinity Drug Design Limited
Financial Statements
Year ended 31 March 2017
Contents
Page
Statement of financial position and the notes to the financial statements
1
Affinity Drug Design Limited
Statement of Financial Position
31 March 2017
2017
2016
£
£
£
£
Fixed assets
572
6,391
----
-------
Current assets
161,796
116,829
Creditors: amounts falling due within one year
18,059
23,564
---------
---------
Net current assets
143,737
93,265
---------
--------
Total assets less current liabilities
144,309
99,656
Provisions for liabilities
114
1,278
Accruals and deferred income
806
756
---------
--------
143,389
97,622
---------
--------
Capital and reserves
143,389
97,622
---------
--------
For the year ending 31 March 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 18 July 2017 , and are signed on behalf of the board by:
P W Finn
A Finn
Director
Director
Company registration number: 08466627
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 41 Cornmarket Street, Oxford, OX1 3HA.